3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
52
Brain Neoplasms
50
Carcinoma, Non-Small-Cell Lung
48
Neoplasm Metastasis
29
Lung Neoplasms
29
Breast Neoplasms
23
Pancreatic Neoplasms
16
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Hepatocellular
13
Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Urinary Bladder Neoplasms
7
Small Cell Lung Carcinoma
7
Colorectal Neoplasms
7
Kidney Neoplasms
5
Liver Neoplasms
4
Glioblastoma
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Prostate Cancer Metastatic
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Adenocarcinoma
3
Interventions
trametinib
5
dabrafenib
5
pembrolizumab
3
lenvatinib
3
cobimetinib
2
cemiplimab
2
atezolizumab
2
Vemurafenib
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
zimberelimab
1
selpercatinib
1
fludarabine
1
cabozantinib
1
aldesleukin
1
Taxes
1
Ipilimumab
1
Immunoglobulin G
1
Disulfides
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Radiosurgery
×
1 year
×
Clear all
No trials found.